TrialTechniques in coloproctology2014

Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn's disease: an open-label, pilot study.

A Tursi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.